While tremendous progress has been made using immunotherapies to treat a variety of cancers, it remains a challenge to predict patient response. Part is due to the inherent complexity of the tumour microenvironment (TME), including the ability to differentiate components and accurately identify their interactions, phenotype and function. Multiplexing spatial imaging technologies can be used to maximise the amount of data collected in the TME, thereby answering more questions from fewer samples.
Hear how Dr. Reece Gardner from Curve Therapeutics uses the Dianthus instrument with Spectral Shift technology to validate Microcycle® hits....
Carrie Haslam
The decisions you make about your biologics candidates early in the pipeline ultimately affect their success as therapeutics. Combine sizing and stabi...
Carrie Haslam
This video reviews the uses and advantages of reporter cell lines in the context of cellular research and drug discovery....
Carrie Haslam
The pipetting robot, flowbot® ONE, is available with a HEPA filter to make clean-up processes easy and effective, enabling you to keep your samples sa...
Carrie Haslam
Dr. Stokes, Associate Director Proteomics, discusses how proteomic studies can increase effectiveness, speed of target and biomarker identification....
Carrie Haslam
The pipetting robot, flowbot® ONE, is available with UV light to make clean-up processes easy and effective, enabling you to keep your samples safe....
Carrie Haslam
Check out our library of NGS-related webinars from global researchers and industry professionals to explore possibilities with our Biomek automated wo...
Drug Target Review
Droplet Digital PCR (ddPCR) offers greater accuracy and precision in quantifying viral titer in gene therapies....
Carrie Haslam
Unlock Exclusive Industry Insights